Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

NHS data show drop in prescribing of dependency-forming medicines

The medicines featured in the NHS Business Services Authority report include gabapentinoids, opioids, benzodiazepines and Z-drugs.…

TB medicines shortage to last until end of 2025

A national patient safety alert has asked hospital procurement teams to review current stocks and work towards accessing licensed and unlicensed supplies, where available.…

MHRA ‘shares concerns’ over failure to meet epilepsy drug prescribing target

Exclusive: Alison Cave, chief safety officer at the MHRA, has echoed concerns about persistent sodium valproate prescribing raised by the Independent Fetal Anti-Convulsant Trust.…

Pharmacy trainees unable to access GPhC exam results

Regulator issues apology after glitch stops foundation-year trainees from getting their registration assessment results.…

NPA warns of ‘spiralling demand’ for NHS weight-loss medications

Survey results revealed that nearly one-quarter of UK adults tried to access weight-loss treatments in the past year via pharmacies.…

Number of adults prescribed ADHD medication rises by a quarter

Data from NHS Business Services Authority show that in 2024/2025, 190,000 adults in England were prescribed medication for attention deficit hyperactivity disorder.…

Stronger regulatory oversight needed for self-testing kits, review concludes

Authors of the cross-sectional review found that nearly three-quarters of over-the-counter testing kits “did not progress or close care pathways”.…

Dale and Appelbe’s Pharmacy and Medicines Law: covering ‘essential ground in the most highly regulated areas of healthcare’

As the 13th edition of Dale and Appelbe’s Pharmacy and Medicines Law is printed for the final time before moving online, its authors Chris Langley and David Reissner reveal what has changed in this latest edition and reiterate its significance for anyone working in pharmacy.…

MHRA approves first needle-free emergency treatment for anaphylaxis

EURneffy, a single-dose nasal spray, is approved for the emergency treatment of anaphylaxis in patients weighing 30kg or more.…

Latest MEP reflects ‘growing complexity of pharmacy practice’

The Royal Pharmaceutical Society’s newest Medicines, Ethics and Practice is the professional guide for pharmacists’ 48th edition.…